Decades of drift must end

Posted 18 January 2021 PM

Decades of government policy 'drift' in developing the pharmaceutical, biotech and medical devices industries has "come home to roost" with Australia lagging internationally, the Zimmerman inquiry into the approval of  new drugs and medical technologies has been told.

The pressures and problems currently facing the industry were predicted in a Productivity Commission report published 16 years ago, with little progress since, former Medicines Australia chief executive and principal of Shawview Consulting, Dr Brendan Shaw said in his submission.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here